TRANSITIONAL CELL CARCINOMA RECURRENT

TRANSITIONAL CELL CARCINOMA RECURRENT was reported 58 times

TRANSITIONAL CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NADOFARAGENE FIRADENOVEC-VNCG 1 0.0019
1 ENFORTUMAB VEDOTIN 14 0.0018
2 BACILLUS CALMETTE-GUERIN 3 0.0017
3 MITOMYCIN 2 0.0005
4 LUSPATERCEPT 1 0.0004
5 HYDROCORTISONE SODIUM SUCCINATE 1 0.0003
6 GEMCITABINE HYDROCHLORIDE 13 0.0002
7 CISPLATIN 14 0.0002
8 PEMBROLIZUMAB 17 0.0002
9 DUTASTERIDE 1 0.0001
10 BOSUTINIB 1 0.0001
11 FILGRASTIM 3 0.0001
12 NIVOLUMAB 6 0.0001
13 PACLITAXEL 6 0.0001
14 EVEROLIMUS TABLETS 1 0.0001
15 CARBOPLATIN 7 0.0001
16 DURVALUMAB 1 0.0000
17 UPADACITINIB 3 0.0000
18 USTEKINUMAB 3 0.0000
19 DOXORUBICIN 2 0.0000
20 EVEROLIMUS 1 0.0000
21 VENETOCLAX 1 0.0000
22 RITUXIMAB 3 0.0000
23 DABIGATRAN ETEXILATE 1 0.0000
24 SULFAMETHOXAZOLE AND TRIMETHOPRIM 1 0.0000
25 LENALIDOMIDE 5 0.0000
26 VEDOLIZUMAB 1 0.0000
27 BORTEZOMIB 1 0.0000
28 PREDNISOLONE ORAL SOLUTION 2 0.0000
29 LEFLUNOMIDE 1 0.0000
30 CYCLOSPORINE 1 0.0000
31 TACROLIMUS OINTMENT 0.1% 1 0.0000
32 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
33 MYCOPHENOLATE MOFETIL 1 0.0000
34 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
35 TACROLIMUS 1 0.0000
36 METHOTREXATE SODIUM 3 0.0000
37 IBUPFROFEN 1 0.0000
38 IBUPROFEN TABLETS USP, 200MG 1 0.0000
39 IBUPROFEN ORAL 1 0.0000
40 IBUPROFEN CAPSULES 200 MG 1 0.0000
41 OXYCODONE HYDROCHLORIDE 1 0.0000
42 FOLIC ACID 1 0.0000
43 AMLODIPINE 1 0.0000
44 IBUPROFEN 1 0.0000
45 DEXAMETHASONE 1.5 MG 1 0.0000
46 DEXAMETHASONE 1 0.0000
47 PREDNISONE 1 0.0000